New EU API rules: No deal for Singapore on equivalency
This article was originally published in SRA
Executive Summary
The European Commission has rejected Singapore's application to be included in the list of third countries that will be exempt from a provision of the EU Falsified Medicines Directive requiring them to issue written confirmations to local manufacturers of active pharmaceutical ingredients (APIs) who wish to export their products to the EU1.